TD Synnex Corporation
TD SYNNEX Reports Fiscal 2025 First Quarter Results and Announces Dividend
Summary
TD SYNNEX Corporation reported its fiscal 2025 first quarter results, with revenue of $14.5 billion, an increase of 4.0% from the prior fiscal first quarter. On a constant currency basis, revenue increased by 6.0%. Diluted earnings per share (EPS) was $1.98, and non-GAAP diluted EPS was $2.80. The company also announced a quarterly cash dividend of $0.44 per common share, payable on April 25, 2025. Non-GAAP gross billings increased by 7.5% to $20.7 billion. Operating income was $304.5 million, with an operating margin of 2.1%. The company returned $138 million to stockholders through share repurchases and dividends.
Get alerts for SNX
Be first to know when TD Synnex Corporation files with the SEC.
Filing Categories
Exhibits (1)
Advertisement
About TD Synnex Corporation
TD Synnex Corporation is a global leader in business process services, specializing in the distribution of technology products and services. The company's primary function is to provide comprehensive supply chain solutions, acting as a vital conduit between technology manufacturers and end-users across various sectors, including IT, education, healthcare, and government. TD Synnex plays a critical role in ensuring the efficient movement of technology products from production to market, thereby enhancing the scalability and reach of its vendor partners. The company offers a broad array of value-added services, such as logistics, integration, and financial services, thus facilitating optimized technology solutions for its clientele. Headquartered in Florida, TD Synnex operates across multiple continents, cementing its market significance as a reliable partner in the ever-evolving tech distribution landscape. It significantly impacts the technology ecosystem by enabling and accelerating access to innovative products and solutions worldwide, thus serving as a backbone for technology deployment in diverse industries.
Official SEC Documents
Advertisement